Fifth Third Wealth Advisors LLC Acquires 1,318 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Fifth Third Wealth Advisors LLC grew its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 14.3% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 10,563 shares of the medical equipment provider's stock after acquiring an additional 1,318 shares during the period. Fifth Third Wealth Advisors LLC's holdings in Intuitive Surgical were worth $5,232,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently bought and sold shares of the company. Marion Wealth Management grew its stake in shares of Intuitive Surgical by 6.2% during the 1st quarter. Marion Wealth Management now owns 410 shares of the medical equipment provider's stock worth $203,000 after purchasing an additional 24 shares during the period. Beese Fulmer Investment Management Inc. grew its stake in Intuitive Surgical by 9.5% in the 1st quarter. Beese Fulmer Investment Management Inc. now owns 1,750 shares of the medical equipment provider's stock valued at $867,000 after acquiring an additional 152 shares during the period. Burns J W & Co. Inc. NY raised its position in Intuitive Surgical by 16.3% during the first quarter. Burns J W & Co. Inc. NY now owns 11,739 shares of the medical equipment provider's stock worth $5,814,000 after acquiring an additional 1,649 shares during the period. Rothschild Investment LLC lifted its holdings in Intuitive Surgical by 16.6% during the first quarter. Rothschild Investment LLC now owns 561 shares of the medical equipment provider's stock valued at $278,000 after purchasing an additional 80 shares in the last quarter. Finally, Global Financial Private Client LLC lifted its stake in Intuitive Surgical by 253.3% in the 1st quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider's stock valued at $26,000 after buying an additional 38 shares in the last quarter. Institutional investors own 83.64% of the company's stock.

Insider Activity at Intuitive Surgical

In related news, Director Jami K. Nachtsheim sold 2,400 shares of the company's stock in a transaction on Thursday, May 1st. The stock was sold at an average price of $520.00, for a total value of $1,248,000.00. Following the completion of the transaction, the director now directly owns 6,371 shares in the company, valued at approximately $3,312,920. This represents a 27.36% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, SVP Mark Brosius sold 489 shares of Intuitive Surgical stock in a transaction dated Friday, March 7th. The shares were sold at an average price of $533.18, for a total transaction of $260,725.02. Following the sale, the senior vice president now owns 2,091 shares in the company, valued at approximately $1,114,879.38. This trade represents a 18.95% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 25,716 shares of company stock worth $12,831,288 in the last 90 days. 0.70% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on the stock. Truist Financial lowered their target price on shares of Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating on the stock in a research note on Wednesday, April 23rd. Robert W. Baird dropped their price objective on shares of Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating for the company in a research note on Wednesday, April 23rd. Barclays decreased their target price on shares of Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating on the stock in a research note on Thursday, April 24th. Evercore ISI dropped their price target on Intuitive Surgical from $510.00 to $470.00 and set an "in-line" rating for the company in a research report on Wednesday, April 23rd. Finally, Erste Group Bank upgraded Intuitive Surgical from a "hold" rating to a "buy" rating in a research report on Thursday. Four analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $596.05.

Intuitive Surgical Trading Up 0.8%

ISRG traded up $4.60 on Thursday, reaching $562.55. The company had a trading volume of 344,385 shares, compared to its average volume of 1,643,157. Intuitive Surgical, Inc. has a one year low of $405.08 and a one year high of $616.00. The company has a market capitalization of $201.63 billion, a P/E ratio of 87.76, a PEG ratio of 5.85 and a beta of 1.67. The company has a fifty day moving average of $519.52 and a 200-day moving average of $538.95.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.71 by $0.10. The company had revenue of $2.25 billion during the quarter, compared to the consensus estimate of $2.19 billion. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. During the same quarter in the prior year, the firm earned $1.50 EPS. Research analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.